Effect of milrinone on coronary artery bypass grafts

被引:2
作者
He, GW
机构
关键词
D O I
10.1016/S0022-5223(97)70171-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:302 / 304
页数:3
相关论文
共 4 条
[1]   Inhibition of vasoconstriction by phosphodiesterase III inhibitor milrinone in human conduit arteries used as coronary bypass grafts [J].
He, GW ;
Yang, CQ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (02) :208-214
[2]   Potential greater than additive vasorelaxant actions of milrinone and nitroglycerin on human conduit arteries [J].
He, GW ;
Yang, CQ ;
Gately, H ;
Furnary, A ;
Swanson, J ;
Ahmad, A ;
Floten, S ;
Wood, J ;
Starr, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (02) :101-107
[3]   Direct vasodilator effect of milrinone, an inotropic drug, on arterial coronary bypass grafts [J].
Liu, JJ ;
Doolan, LA ;
Xie, B ;
Chen, JR ;
Burton, BF .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (01) :108-113
[4]   HYPOPERFUSION AFTER ARTERIAL BYPASS-GRAFTING [J].
LOOP, FD ;
THOMAS, JD .
ANNALS OF THORACIC SURGERY, 1993, 56 (04) :812-813